+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022 - Product Thumbnail Image

Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022

  • Clinical Trials
  • November 2022
  • 80 Pages
  • Global
From
TIGIT Inhibitors - Competitive Landscape, 2022 - Product Thumbnail Image

TIGIT Inhibitors - Competitive Landscape, 2022

  • Report
  • October 2022
  • 100 Pages
  • Global
From
Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 162 Pages
  • Global
From
From
From
Brain Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Brain Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
Fibrocystic Breast Condition - Epidemiology Forecast - 2032 - Product Thumbnail Image

Fibrocystic Breast Condition - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Paranasal Sinus Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Paranasal Sinus Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Myeloproliferative Neoplasms - Epidemiology Forecast - 2032 - Product Thumbnail Image

Myeloproliferative Neoplasms - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Bone Metastasis in Solid Tumors - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bone Metastasis in Solid Tumors - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Prostate cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Prostate cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Xospata - Drug Insight, 2019 - Product Thumbnail Image

Xospata - Drug Insight, 2019

  • Report
  • July 2019
  • Global
From
Erleada - Drug Insight, 2019 - Product Thumbnail Image

Erleada - Drug Insight, 2019

  • Report
  • July 2019
  • Global
From
Lutathera - Drug Insight, 2019 - Product Thumbnail Image

Lutathera - Drug Insight, 2019

  • Report
  • July 2019
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more